Optimizing LUTS and OAB Management: Striving for personalized approaches

Optimizing LUTS and OAB Management: Striving for personalized approaches

Join us at the Pierre Fabre Industry Symposium at EAU 2025 for an engaging session on optimizing LUTS and OAB management. This symposium, scheduled for Saturday, March 22, 2025, from 14:15 to 15:15, will feature presentations from leading experts in the field. Gain insights into the latest clinical research, personalized treatment approaches, and innovative strategies for managing LUTS and OAB. This event is a must-attend for physicians looking to enhance their practice with cutting-edge knowledge. Don't miss the opportunity to learn from top specialists, and engage in interactive discussions.

Our objectives for this symposium is to cover the following topics:

Current Challenges and Gaps:

• Introduction of the topic of personalized approaches and personalized treatment plans for LUTS

Innovative Research and Data: Tailored Treatment Strategies and Future Directions:

• Updates on the natural history and pathophysiology of LUTS and OAB to better understand patient variability, discussions on the role of urodynamics, and on the importance of the initial assessment and to consider the type of predominant symptoms without always focusing on the prostate, to define the treatment plan.
• Discussions on how to tailor treatments for specific conditions like BPO and BPE, including exploration of emerging technologies and methodologies that could facilitate more personalized management in the future (pharmacological and surgical treatment)
• Discussion on interest of phenotyping in developing individualized treatment plans, in particular for OAB, including exploration of emerging technologies and methodologies that could facilitate more personalized management in the future.

Latest clinical research finding on pharmacological treatments

• Presentation of the latest clinical data, particularly regarding the pharmacological treatment of OAB. 

Interactive Learning:

• Real-life clinical cases presented in an interactive format to engage the audience in problem-solving and decision-making: Case studies and examples of individualized treatment plans, including both pharmacological and surgical options.

Cosimo De Nunzio graduated at the University “La Sapienza”, Roma where he completed his urological residency in 2002 and a PhD in advanced surgical technologies in 2006. He held fellowships from the University of Newcastle, Sheffield and Paris. Since 2006 he is consultant urologist at the Ospedale Sant’Andrea, Rome and since 2021 he is Associate Professor of Urology at the Faculty of Medicine and Psychology, Sapienza University of Rome.  His research is focused on prostatic diseases and uro-oncology including laparoscopic, robotic and minimally invasive treatments. He has authored or coauthored over 800 peer-reviewed articles. He serves as Editor in Chief of Prostatic Cancer and Prostatic Diseases.

Benoit Peyronnet is Associate Professor at the Rennes University department of Urology, Rennes, France where he is the head of the neurourology and functional urology program. He completed his medical school at the Paris VI university, his residency at the University of Rennes, Toulouse and Tours and clinical fellowship at the university of Rennes. He then did a 1-year research fellowship in the FPMRS division of the New York University Department of Urology. In 2019, he obtained a PhD at the University of Rennes on the molecular and radiomical characterization of spina bifida lower urinary tract dysfunction. His academic interests and clinical practices are focused on functional urology, neurourology, reconstructive urology and robotics. He has authored or coauthored over 800 peer-reviewed articles. He is a panel member of the EAU guidelines panel on female LUTS, of the ICS 7th International Consultation on Incontinence on female urinary incontinence surgery and of the French neurourology committee. He is an associate editor for Progres en Urologie, World Journal of Urology and Current Bladder Dysfunction Reports.

David R. Staskin, MD, practices in Boston, MA at Tufts University School of Medicine, St. Elizabeth's Medical Center-Steward Health. He has served on the faculties of Harvard (Beth Israel), Cornell (Weill Cornell) and Boston University Medical Schools. He has participated as a member of the International Consultation on Incontinence International Consultation on Urological Diseases Guidelines and the American Urological Association's Surgical Management of Female Stress Urinary Incontinence Committee. He has also participated on the board of directors of the Society for Urodynamics and Female Urology, the American Association of Clinical Urologists, and the American Urogynecological Society. Dr. Staskin has published extensively in the areas of lower urinary tract symptoms, female urology, neuro-urology, and urodynamics (>170 articles). He is co-editor of the 5 editions of Textbook of Female Urology and Urogynecology (Cardozo and Staskin, eds). He holds multiple issued patents, and is the SPARC/ArcSP™ and RetroARC/ArcTV™ Sling Systems.

Dr. Manuela Tutolo is currently a full staff urologist and researcher at San Raffaele Scientific Hospital in Milan, Italy. During her residency she completed a one-year basic research programme at the Urological Research Institute in Milan. After residency, she completed a one-year clinical fellowship in functional urology at the University Hospital of Leuven, Belgium, under the supervision of Prof. Dirk De Ridder. In addition, she worked for three years as an expert consultant at the Belgian Multiple Sclerosis Centre and the Gashuisberg Hospital in Leuven, improving her skills in the field of neuro-urology. She achieved her PhD in biomedical sciences from KU Leuven in 2023 under the supervision of Prof. Frank Van der Aa.

Dr. Tutolo is a member of the European Guidelines Committee on Male LUTS and actively collaborates with the Young Academic Urologists’ Group on Functional Urology of the EAU. Her scientific research mainly focuses on male and female LUTS and neuro-urology.

HQ--02-25-2500037